UPDATE -- Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19 with Planned Completion and Emergency Use Authorization Request
Stock Information for Revive Therapeutics Ltd
Loading
Please wait while we load your information from QuoteMedia.